Skip Navigation

Cardiovascular Research 1998 39(3):589-599; doi:10.1016/S0008-6363(98)00166-7
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Suzuki, M.
Right arrow Articles by Cheng, C.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, M.
Right arrow Articles by Cheng, C.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy

Makoto Suzukia, Nobuyuki Ohtea, Zhong-Min Wanga, David L. Williams, Jr.b, William C. Littlea and Che-Ping Chenga,*

aCardiology Section, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1045, USA
bMerck and Co., Inc., Merck Research Laboratories, West Point, PA 19486, USA

* Corresponding author. Tel.: +33-6-716-2887; Fax: +33-6-716-9188.

Objective: The positive inotropic effect of endothelin-1 (ET-1) on normal myocardial contraction may be altered in pathological states. The purpose of this study was to assess the direct effect of ET-1 on cardiomyocyte performance and its cellular mechanism in congestive heart failure (CHF). Methods: We measured the plasma levels of ET-1 and compared the effects of ET-1 (10–10–10–8 M) on contractile performance and the [Ca2+]i transient in the myocytes of left ventricles (LV) from 15 age-matched normal adult rats and 15 rats with isoproterenol (ISO)-induced CHF. Results: With CHF, the plasma levels of ET-1 (19.7±6.3 vs. 4.1±0.5 fmol/ml, p<0.05) were markedly elevated. In normal myocytes, superfusion of ET-1 caused significant increases in the systolic amplitude (SA, 8–16%) and the peak velocity of shortening (dL/dtmax, 20–35%; p<0.01) without causing a change in the peak [Ca2+]i transient. In contrast, in myocytes from CHF rats, ET-1 produced significant reductions in SA (9–13%) and in the velocity of relengthening, dR/dtmax (10–14%; p<0.05). The myocytes' dR/dtmax also decreased by 8–10% (p<0.05). These changes were associated with a significant decrease in the peak [Ca2+]i transient (20–23%, p<0.0 1). These responses to ET-1 were abolished by the incubation of myocytes with an ETA receptor antagonist (BQ123) or a protein kinase C (PKC) inhibitor (H-7 or staurosporine). Conclusion: ISO-induced CHF is associated with elevated plasma ET-1 and an altered cardiomyocyte response to ET-1. After CHF, ET-1 produces a direct depression of cardiomyocyte contractile performance that is associated with a significant decrease in the peak [Ca2+]i transient. These effects are likely to be mediated through ETA receptors and involve the PKC pathway.

KEYWORDS Rat; Isoproterenol; Congestive heart failure; Endothelin-1; Contraction; Relaxation; Cardiomyocyte; [Ca2+]i transient, Na+–H+ exchange; Protein kinase C


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Y. Chung, M. Kang, and J. W. Walker
Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2391 - H2399.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. Kang, K. Y. Chung, and J. W. Walker
G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart
Physiology, June 1, 2007; 22(3): 174 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. E. Osadchii, G. R. Norton, R. McKechnie, D. Deftereos, and A. J. Woodiwiss
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1898 - H1905.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-S. Zhang, H.-J. Cheng, K. Onishi, N. Ohte, T. Wannenburg, and C.-P. Cheng
Enhanced Inhibition of L-type Ca2+ Current by {beta}3-Adrenergic Stimulation in Failing Rat Heart
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1203 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Morimoto, H. Hasegawa, H.-J. Cheng, W. C. Little, and C.-P. Cheng
Endogenous {beta}3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2425 - H2433.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi
Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2034 - 2038.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. G. Spinale
The bioactive peptide endothelin causes multiple biologic responses relevant to myocardial and vascular performance after cardiac surgery
J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1031 - 1034.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-S. Zhang, H.-J. Cheng, T. Ukai, H. Tachibana, and C.-P. Cheng
Enhanced Cardiac L-Type Calcium Current Response to beta 2-Adrenergic Stimulation in Heart Failure
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 188 - 196.
[Abstract] [Full Text]


Home page
NEJMHome page
M. Packer, A. J.S. Coats, M. B. Fowler, H. A. Katus, H. Krum, P. Mohacsi, J. L. Rouleau, M. Tendera, A. Castaigne, E. B. Roecker, et al.
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
N. Engl. J. Med., May 31, 2001; 344(22): 1651 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-P. Cheng, T. Ukai, K. Onishi, N. Ohte, M. Suzuki, Z.-S. Zhang, H.-J. Cheng, H. Tachibana, A. Igawa, and W. C. Little
The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1853 - H1860.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. A. Walker, S. C. Baicu, A. T. Goldberg, C. E. Widener, D. J. Fary, D. K. Almany, A. Ergul, F. A. Crawford Jr, and F. G. Spinale
Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 864 - 871.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-T. Shen, P. S Buie, J. J Lynch, S. M Krause, and X.-L. Ma
Chronic therapy with an ETA/B receptor antagonist in conscious dogs during progression of congestive heart failure: Intracellular Ca2+ regulation and nitric oxide mediated coronary relaxation
Cardiovasc Res, November 1, 2000; 48(2): 332 - 345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Ergul, C. A. Walker, A. Goldberg, S. C. Baicu, J. W. Hendrick, M. K. King, and F. G. Spinale
ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2050 - H2056.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Onishi, M. Ohno, W. C. Little, and C.-P. Cheng
Endogenous Endothelin-1 Depresses Left Ventricular Systolic and Diastolic Performance in Congestive Heart Failure
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1214 - 1222.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H.-J. Cheng, Z.-S. Zhang, K. Onishi, T. Ukai, D. C. Sane, and C.-P. Cheng
Upregulation of Functional {beta}3-Adrenergic Receptor in the Failing Canine Myocardium
Circ. Res., September 28, 2001; 89(7): 599 - 606.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.